CAS 200189-97-5

CGP 3466B maleate

CAS: 200189-97-5

CGP 3466B (Omigapil) is an oral drug inhibiting GAPDH nitrosylation and apoptosis, potentially treating Alzheimer's and CMD.

Fórmula: C₂₃H₂₁NO₅

Pureza: 98.58%

Cor e Forma: Solid

Peso molecular: 391.42

Ref: TM-T21792

Omigapil Maleate

Produto Controlado

CAS: 200189-97-5

Fórmula: C₁₉H₁₇NO·C₄H₄O₄

Cor e Forma: Neat

Peso molecular: 391.416

Ref: TR-O640000

Omigapil Maleate

CAS: 200189-97-5

Omigapil Maleate is a neurotrophic factor that has been shown to inhibit the production of neuronal death. It has also shown neuroprotective effects in vivo in an animal model, and may be effective in treating Parkinson's disease. Omigapil Maleate inhibits the enzyme propargylamine, which is involved in the synthesis of collagen. This drug also prevents uptake of dopamine into cells by blocking its transport system at the cellular organelle level. Omigapil Maleate binds to dopamine receptors on the nerve cell surface and enhances dopamine release from nerve endings, resulting in increased levels of this neurotransmitter in the brain.

Fórmula: C₂₃H₂₁NO₅

Pureza: Min. 95%

Peso molecular: 391.42 g/mol

Ref: 3D-AIA18997